Lyell Immunopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
South San Francisco, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Lyell Immunopharma, Inc. has filed 339 SEC EDGAR filings since 20 Mar 2020

SEC filing history

Showing 126-150 of 339 matching filings.

Per page
25
Current page
6
PRE 14A File 001-40502

PRE 14A

Filing date
10 Apr 2025
Reporting date
15 May 2025
Next action
Verify source filing
4

4 filing

Filing date
02 Apr 2025
Reporting date
31 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Mar 2025
Reporting date
21 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Mar 2025
Reporting date
17 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
18 Mar 2025
Reporting date
14 Mar 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 File 333-285717

S-8

Filing date
11 Mar 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
26 Feb 2025
Reporting date
10 Feb 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
14 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-93402

SCHEDULE 13G/A filing

Filing date
05 Feb 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-283533

424B5

Filing date
09 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-283533

EFFECT filing

Filing date
05 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
03 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD File 333-283533

UPLOAD filing

Filing date
03 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .